Strides Pharma Q1 PAT up 81% to Rs 114 cr
x
Strides Pharma Science reports 81% YoY rise in profit after tax (PAT) to Rs 114 crore in Q1 FY2026. Revenue also increased.
New Delhi, Jul 29 (PTI) Strides Pharma Science on Tuesday said its profit after tax increased 81 per cent year-on-year to Rs 114 crore for the first quarter ended June 30, 2025.
The company reported a profit after tax (PAT) of Rs 63 crore for the April-June period of last year.
Revenue rose to Rs 1,120 crore for the June quarter against Rs 1,054 crore in the year-ago period, Strides Pharma Science said in a regulatory filing.
"Our focus on cost management and diligent execution has enabled us to deliver robust results," Strides Pharma Science MD & Group CEO Badree Komandur said.
The company will enhance its R&D efforts during the year to drive sustainable long-term growth, he added.
Shares of Strides Pharma were trading 4.71 per cent higher at Rs 965.95 apiece on the BSE.
The company reported a profit after tax (PAT) of Rs 63 crore for the April-June period of last year.
Revenue rose to Rs 1,120 crore for the June quarter against Rs 1,054 crore in the year-ago period, Strides Pharma Science said in a regulatory filing.
"Our focus on cost management and diligent execution has enabled us to deliver robust results," Strides Pharma Science MD & Group CEO Badree Komandur said.
The company will enhance its R&D efforts during the year to drive sustainable long-term growth, he added.
Shares of Strides Pharma were trading 4.71 per cent higher at Rs 965.95 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone-Idea
- 11.14 ( -1.94)
- 19920798
- Welcure-Drugs-and
- 0.46 ( -4.17)
- 16926459
- Sylph-Technologies
- 1.02 (+ 5.15)
- 12504278
- Meesho-L
- 188.30 (+ 10.28)
- 7375277
- Sunshine-Capital
- 0.27 (+ 3.85)
- 6043232
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback